Mercaptopurine: Difference between revisions

From Medicine GPT
Jump to navigation Jump to search
(CSV import)
 
(CSV import)
 
Line 1: Line 1:
{{Definitions
{{Definitions
|Term=Mercaptopurine
|Term=Mercaptopurine
|Short definition=MEPACT - A drug being studied for the treatment of young adults with bone cancer that has gotten worse or has come back. MEPACT activates certain types of white blood cells and helps the immune system kill cancer cells
|Short definition=Mercaptopurine - {{Pronunciation}} (mer-KAP-toh-PYOOR-een) medicine used with other medicines to treat adults and children with acute lymphoblastic leukaemia. It is also being studied in the treatment of other types of cancer. 
|Type=Cancer terms
|Type=Cancer terms
|Specialty=Oncology
|Specialty=Oncology

Latest revision as of 10:27, 12 January 2023

Mercaptopurine
TermMercaptopurine
Short definitionMercaptopurine - (pronounced) (mer-KAP-toh-PYOOR-een) medicine used with other medicines to treat adults and children with acute lymphoblastic leukaemia. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Mercaptopurine - (pronounced) (mer-KAP-toh-PYOOR-een) medicine used with other medicines to treat adults and children with acute lymphoblastic leukaemia. It is also being studied in the treatment of other types of cancer. Mercaptopurine stops cells from making DNA and can kill cancer cells. It's a type of antimetabolite. Also called Purinethol and Purixan

External links

Esculaap.svg

This MedicineGPT article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski